Factors associated to COVID-19 vaccine acceptance in Mexican patients with rheumatic diseases: A cross-sectional and multicenter study

COVID-19 vaccination is recommended in patients with rheumatic diseases (RDs) to prevent hospitalized COVID-19 and worse outcomes. However, patients’ willingness to receive a SARS-CoV-2 vaccine and the associated factors vary across populations, vaccines, and time. The objective was to identify fact...

Full description

Bibliographic Details
Main Authors: Guillermo Arturo Guaracha-Basañez, Irazú Contreras-Yáñez, Everardo Álvarez-Hernández, Greta Reyes-Cordero, Diana Elsa Flores-Alvarado, Susana Aidée González-Chávez, Dionicio Ángel Galarza-Delgado, Perla Rocío Martínez-Leyva, José Francisco Moctezuma-Ríos, Conrado García-García, Gabriel Medrano-Ramírez, Alfonso Gastelum-Strozzi, César Pacheco-Tena, Ingris Peláez-Ballestas, Virginia Pascual-Ramos
Format: Article
Language:English
Published: Taylor & Francis Group 2022-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2022.2049131